Literature DB >> 17728709

Interleukin 2 for patients with renal cancer.

Steven A Rosenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17728709      PMCID： PMC2147080          DOI： 10.1038/ncponc0926

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN： 1743-4254


× No keyword cloud information.
  18 in total

Review 1.  Targeting neoantigens to augment antitumour immunity.

Authors:  Mark Yarchoan; Burles A Johnson; Eric R Lutz; Daniel A Laheru; Elizabeth M Jaffee
Journal:  Nat Rev Cancer       Date:  2017-02-24       Impact factor: 60.716

Review 2.  A review of cancer immunotherapy: from the past, to the present, to the future.

Authors:  K Esfahani; L Roudaia; N Buhlaiga; S V Del Rincon; N Papneja; W H Miller
Journal:  Curr Oncol       Date:  2020-04-01       Impact factor: 3.677

3.  Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice.

Authors:  Barbara Ziffels; Marco Stringhini; Philipp Probst; Tim Fugmann; Theo Sturm; Dario Neri
Journal:  Mol Cancer Ther       Date:  2019-06-18       Impact factor: 6.261

Review 4.  Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.

Authors:  Zachary B Davis; Daniel A Vallera; Jeffrey S Miller; Martin Felices
Journal:  Semin Immunol       Date:  2017-09-05       Impact factor: 11.130

Review 5.  Immunotherapeutic strategies in kidney cancer--when TKIs are not enough.

Authors:  Swethajit Biswas; Tim Eisen
Journal:  Nat Rev Clin Oncol       Date:  2009-06-23       Impact factor: 66.675

6.  The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.

Authors:  Michael Rouse; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Immunobiology       Date:  2012-08-09       Impact factor: 3.144

Review 7.  Effects of obesity on immune responses to renal tumors.

Authors:  Vincent Chehval; Lyse A Norian
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

8.  Quantifying the limits of CAR T-cell delivery in mice and men.

Authors:  Liam V Brown; Eamonn A Gaffney; Ann Ager; Jonathan Wagg; Mark C Coles
Journal:  J R Soc Interface       Date:  2021-03-03       Impact factor: 4.118

9.  Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma.

Authors:  Elfriede Noessner; Dorothee Brech; Anna N Mendler; Ilias Masouris; Ramona Schlenker; Petra U Prinz
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

Review 10.  Clinical studies applying cytokine-induced killer cells for the treatment of renal cell carcinoma.

Authors:  Clara E Jäkel; Stefan Hauser; Sebastian Rogenhofer; Stefan C Müller; P Brossart; Ingo G H Schmidt-Wolf
Journal:  Clin Dev Immunol       Date:  2012-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.